Kaiser Permanente Northern California at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Kaiser Permanente Northern California brings 8 presentations to IDWeek 2026 in Washington. Its program centres on RSV and other respiratory viruses and on vaccine safety and effectiveness, much of it in children. Concrete topics include how maternal RSV vaccination compares with infant nirsevimab and whether COVID-19 in early pregnancy raises the risk of congenital heart disease.

OrganizationIDWeek 2026 Attendance
Talk
Thu Oct 22
10:30am–10:45am
Part of Pediatric Immunizations
Household exposure to hepatitis B virus in children <5 years within Kaiser Permanente Northern California
103 AB
HIV, sexually transmitted infections and viral hepatitisVaccines
Poster
Thu Oct 22
12:15pm–1:30pm
COVID-19 in early pregnancy and risk of infant congenital heart disease
Poster Hall B-C · Poster P-1740
P7. Pediatric Maternal-child infections
Session
Thu Oct 22
1:45pm–3:00pm
Challenging Cases in Pediatric Infectious Diseases​
202 AB
Global ID · with Indiana University, Kaiser Permanente Southern California, Emory University +3 more
Talk
Sat Oct 24
11:00am–11:15am
Part of Maternal/Infant RSV Immunization
Comparative effectiveness of maternal RSVpreF vaccination and infant nirsevimab against RSV among infants in northern California, 2023-2025
201
VaccinesRespiratory infections and COVID-19
Talk
Sat Oct 24
11:06am–11:18am
Part of Fast, Furious and Flawless: Future of ID Testing
Impact of rapid blood culture identification (BCID) on management of common blood culture contaminant organisms in emergency department-discharged patients
209 ABC
Diagnostics and diagnostic stewardshipAntimicrobials, resistance and stewardship
Poster
Sat Oct 24
12:15pm–1:30pm
Evaluation of the Safety of Recombinant Zoster Vaccine Using a Self-Controlled Risk Interval Analysis in the Vaccine Safety Datalink
Poster Hall B-C · Poster P-1190
I1. Adult Vaccines
Poster
Sat Oct 24
12:15pm–1:30pm
Incidence of COVID, Influenza, and RSV during two respiratory seasons in the US, 2023-2025
Poster Hall B-C · Poster P-445
C4. Respiratory infections - viral
Poster
Sat Oct 24
12:15pm–1:30pm
Two-season nirsevimab effectiveness against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in healthy term infants immunized during their first season
Poster Hall B-C · Poster P-1181
I2. Pediatric Vaccines

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Kaiser Permanente Northern California

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction